Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen
Jansen, Maurice Phm, Martens, John Wm, Helmijr, Jean Ca, Beaufort, Corine M, van Marion, Ronald, Krol, Niels Mg, Monkhorst, Kim, Trapman-Jansen, Anita Mac, Meijer-van Gelder, Marion E, Weerts, Marjolein Ja, Ramirez-Ardila, Diana E, Dubbink, Hendrikus Jan, Foekens, John A, Sleijfer, Stefan, Berns, Els Mjj
Published in Oncotarget (12.07.2016)
Published in Oncotarget (12.07.2016)
Get full text
Journal Article
LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome
Ramirez-Ardila, Diana E., Ruigrok-Ritstier, Kirsten, Helmijr, Jean C., Look, Maxime P., van Laere, Steven, Dirix, Luc, Berns, Els M.J.J., Jansen, Maurice P.H.M.
Published in Molecular oncology (01.10.2016)
Published in Molecular oncology (01.10.2016)
Get full text
Journal Article
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen
Ramirez-Ardila, Diana E., Helmijr, Jean C., Look, Maxime P., Lurkin, Irene, Ruigrok-Ritstier, Kirsten, van Laere, Steven, Dirix, Luc, Sweep, Fred C., Span, Paul N., Linn, Sabine C., Foekens, John A., Sleijfer, Stefan, Berns, Els M. J. J., Jansen, Maurice P. H. M.
Published in Breast cancer research and treatment (01.05.2013)
Published in Breast cancer research and treatment (01.05.2013)
Get full text
Journal Article
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifenbr
Ramirez-ardila, Diana E, Helmijr, Jean C, Look, Maxime P, Lurkin, Irene, Ruigrok-ritstier, Kirsten, van Laere, Steven, Dirix, Luc, Sweep, Fred C, Span, Paul N, Linn, Sabine C, Foekens, John A, Sleijfer, Stefan, Berns, Els M; J; J, Jansen, Maurice P; H; M
Published in Breast cancer research and treatment (01.05.2013)
Published in Breast cancer research and treatment (01.05.2013)
Get full text
Journal Article